NHX

Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)

Product code
NHX
Device name
Antibodies, Anti-Cyclic Citrullinated Peptide (Ccp)
Device class
Class 2
21 CFR
21 CFR 866.5775
Medical specialty
Immunology
Marketing pathway
510(K)
Flag
Third-party review eligible
510(k) clearances (all years, FDA)
21 (all years; only the last 3 years are listed here)

FDA classification definition

The device is used for the detection of anti-cyclic citrullinated peptide (CCP) antibodies in human serum or plasma as an aid in the diagnosis of rheumatoid arthritis.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: NHX
Classification and pathway per current FDA publications. Data from openFDA (CC0).